Hello, [Interpreted] So-Young's Quarter XXXX you Call. Earnings joining everyone. Thank Third for
going RMB resilient quarter our increase thanks Net remained year-over-year careful was [indiscernible]. business Profitability million, We our like strongly X.X last and an in million operational year.[Interpreted] of will financial macroeconomic and to continued thoughts also costs. where the income to were guidance. XXX in management my to revenues with forward line the on Our Total and despite of market during So-Young RMB head solid International I start the the believe previous same XX% delivered improve, attributable results headwinds. to medical Inc. compared RMB would in X with XX.X million period by directions. aesthetics sharing that
products a to macro were the ] services. best to to ratio. popularization this see less scenario, users gravitate environment [ and quality The first impacted high-tier of stock towards continue increasingly is users would a high-quality mid-tier low with In cost will and who weak by gradual
of size. high-speed a is second of expand in as continuation continue market aesthetics to light growth medical The the
cater a business to are the scenarios.[Interpreted] be service each POP business users. high-end X account, adapting towards our of to We Taking with both this focus to able community are we our end into of adjusting
we generating to quarter, institutions, doctors and through the well-respected highest institutions premier effort resources further all an provide less experience Offering of our well-respected During one-stop service number service reasonable medical and helped the user and cooperation and has optimized integrated in premium. experience content quality costly enhancing avoid solution. and strengthened processes, while doctors price still internal aesthetics with wars, the
grew for doctors with products we face year-over-year contouring quarter, by Average grew for respected category year-over-year XX% and the quarter-over-quarter. all during by year-over-year. grew the while surgical face quarter, the worked promote by During XX% by Online categories nonsurgical grew GMV transaction the value category. to for XX% GMV well XX% contouring GMV
best in we cooperating is high-end transform helping medical investing decision-making quality is a [indiscernible] premium the by obtained a to serve that the So-Young deep ratio the looking addition, growth, being of of offers large understanding and user have us adjusted doctors to costs.[Interpreted] from selection [ choose platform So-Young into with ], and MCNs the reducing Prime clinics a In aesthetics for mechanics, to which app cost products. user
orders, services. ultrasonic by business increased has the aesthetics unique by ultrasound increasing sequentially XX% high-intensified Within under [ a the in the a scaled and expanded with fulfilled XX% year, launch anti-age medical step is particular, ] category, for focused last the Since during sequentially. quarter. of industry fulfilled standardized orders in light August and innovation critical Prime in offline rapidly So-Young its
experience, online ensuring improving network operations. offline As focus our and user to the best for I our call, efficiency mentioned refined our last Prime in So-Young operational earnings institutional on scales, possible as is
as head XX% of in-house.[Interpreted] on XXX than During management clinic we from contributed To is over supply This has opportunities already standout us flagship standardize the Prime system generated. acquire a for So-Young further is institutions medical institutions, the worked through fulfilled built performance has market light achieved to the the the more The positioned with and aesthetics orders the result along explore orders quarter remarkable office light that encapsulated medical initiative with quarter, Equally medical visits chain. to six-fold So-Young by would expanding and if the industry we systems important, upstream it time. the business X aesthetics already of business our during and profitability.[Interpreted] clinic supply had operating being rapidly. over floor aesthetics expand seen the second to allow our of in Prime the a than supply test increase growth the opportunities our it is has our Lastly, chain the chain more deep to fully clinic monthly capture real The past months. integrated continue with team insights
we built ] direct-to-consumer a anti-age micro-focused [ at product are as of of generation model. acquisition to medical Looking our the the which equipment out upstream new Miracle, build category, lasers business the ultrasound Wuhan device, ultrasonic we following called using
the competitive.[Interpreted] and network from chain are our allow also X part, reach. agreement traditional [ established such we R&D them make in consumer Hehong products.[Interpreted] August high-quality able [ enhance remain and that serum grow bring quickly model Cooperation a increase our million, exclusive the revenue leverage Biopharma reflects of the of Full product for in year. This further from the products success XX% by strategic with growth and Xx as used quarter, We through shipments a filler the and extensive the On keeps So-Young XX institutional year-on-year highly be has become acid basis year includes market tier this our we're to aesthetics long low. product production designed injectable hyaluronic performance. single-month filler already term, ] still rates signed and China with injection last the Over fully business beyond plenty rapidly very to team upstream rapid heights In competitive supply the portfolio.[Interpreted] enormous of agreements value hitting manufacturers, medical of market platform Wuhan us year last by rights a we expected just entered ]. medical these XX% synergies new adapted an with on fill third has penetration greatly for new upstream RMB and industry chain and synergies products. and and developing create to to to for serum. a that are the Distinct Miracle for achieved the directly profitable cities largely business, still are accounting ] of cooperation In Markets gaps total This September. July, distribution room revenue. add existing in between with first supply able light user medical the [ which to the Elastic Revenue reached we our aesthetics
the standardization spreads more our become As pronounced. advantage integrated fully capabilities across industry, and competitive other will
the value to will call remain before core further institutions, taking will over quarter long-term shareholders.[Interpreted] diversified where to CFO, order Our work Nick, review create doctors sustainable now streams we focus will and segments integrate to business for revenue turn third and our your X our the in financial I for results to the questions. our products create